Earnings History Data for Swedish Orphan Biovitrum (BIOVF) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Swedish Orphan Biovitrum
Swedish Orphan Biovitrum is a biotechnology company. It develops, manufactures and sells medications within hemophilia, autoimmune diseases, metabolic diseases and cancer supportive care. The Company's product portfolio consists of Core Products segment which offers pharmaceuticals within Inflammation area and Genetics and metabolic therapeutic area; Partner Products segment which offers pharmaceuticals within hematology, oncology and emergency medicines, and the ReFacto Manufacturing segment. The company operates primarily in Sweden, Denmark, Finland, Norway, United Kingdom and France. Swedish Orphan Biovitrum is based in Solna, Sweden.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08-02-2024 | PM | BIOVF | Swedish Orphan Biovitrum | 0.00 | 0.30 | 0.56 | 0.00 | Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.21, revenue of SEK6.84B [2/8/2024 6:11 AM] |
27.00 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
17.58 - 27.00 | 40 | 0 | 0 | ||
| 30-10-2023 | PM | BIOVF | Swedish Orphan Biovitrum | 5,770 | 0.05 | 0.09 | 0.00 | Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK0.54, revenue of SEK5.17B [10/30/2023 12:17 PM] |
20.00 | 0.45 (2.30%) |
0.0 | 0.0 (0.00%) |
17.43 - 25.29 | 133 | 0 | 0 | ||
| 18-07-2023 | PM | BIOVF | Swedish Orphan Biovitrum | 5,739 | 0.14 | 0.11 | 0.00 | Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK1.48, revenue of SEK4.87M misses by SEK419.36M [7/18/2023 8:24 AM] |
20.27 | 0.82 (4.24%) |
0.0 | 0.0 (0.00%) |
18.25 - 26.48 | 550 | 0 | 0 | ||
| 27-04-2023 | PM | BIOVF | Swedish Orphan Biovitrum | 7,792 | 0.34 | 0.22 | 0.00 | Swedish Orphan Biovitrum AB Non-GAAP EPS of SEK3.60, revenue of SEK5.24B [4/27/2023 12:54 PM] |
26.40 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
18.25 - 26.48 | 0 | 0 | 0 | ||
| 08-02-2023 | PM | BIOVF | Swedish Orphan Biovitrum | 6,679 | 0.43 | 0.44 | 0.00 | Swedish Orphan Biovitrum AB reports Q4 earnings; issues FY23 soft guidance [2/8/2023 7:48 AM] |
23.36 | 0.81 (3.59%) |
0.0 | 0.0 (0.00%) |
18.25 - 24.50 | 733 | 0 | 0 | ||
| 27-10-2022 | PM | BIOVF | Swedish Orphan Biovitrum | 5,387 | 0.14 | 0.12 | 0.00 | Swedish Orphan Biovitrum AB GAAP EPS of SEK 1.52, revenue of SEK 4B [10/27/2022 4:50 AM] |
18.25 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
18.25 - 27.15 | 0 | 0 | 0 | ||
| 19-07-2022 | PM | BIOVF | Swedish Orphan Biovitrum | 6,426 | 0.09 | 0.08 | 0.00 | Swedish Orphan Biovitrum AB Non-GAAP EPS of -SEK0.91, revenue of SEK3.87M misses by SEK352.44M [7/19/2022 8:35 AM] |
21.20 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
18.05 - 28.88 | 100 | 0 | 0 | ||
| 04-05-2021 | PM | BIOVF | Swedish Orp Bio | 5,190 | 0.28 | 0.31 | 0.00 | Swedish Orphan Biovitrum AB reports Q1 results [5/4/2021 8:10 AM] |
0.0 | 0.0 (0.00%) |
0.0 | 0.0 (0.00%) |
0.0 - 0.0 | 0 | 0 | 0 | ||